6:12 PM ET
Form 4
Insider Buying
Retension Pharmaceuticals CEO Eric L. Keller Buys $250K of Stock
Eric L. Keller, CEO, bought 20,800 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $250K in total on Oct 13, 2026. Shares held after the trade: 423,377 (+5.2%).
- Value
- $250K
- Shares
- 20,800
- Price
- $12.00
- Role
- CEO
- Holding change
- +5.2%
- Trade date
- Oct 13, 2026